Pelthos Therapeutics (PTHS) EPS (Diluted) (2023 - 2026)
Powered by 
Analysis
Pelthos Therapeutics (PTHS) EPS (Diluted) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.96 Bn | 621.20 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 446.03 Bn | 439.46 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 357.59 Bn | 350.45 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 268.36 Bn | 260.67 Bn | 11.24 Bn | 1.67 |
| 5 | Pfizer | 156.47 Bn | 144.77 Bn | 10.94 Bn | -0.04 |
| 6 | Sanofi | 52.24 Bn | 44.86 Bn | 10.79 Bn | 0.33 |
| 7 | Revolution Medicines | 43.12 Bn | 43.12 Bn | - | -3.06 |
| 8 | Incyte | 24.82 Bn | 20.28 Bn | 1.57 Bn | 2.81 |
| 9 | United Therapeutics | 21.45 Bn | 18.79 Bn | 683.80 Mn | 7.27 |
| 10 | Pelthos Therapeutics | 80.38 Mn | 55.82 Mn | 21.23 Mn | -13.70 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -13.70 |
| Mar 31, 2026 | -7.57 |
| Dec 31, 2025 | -11.52 |
| Sep 30, 2025 | -5.30 |
| Jun 30, 2025 | 5.46 |
| Mar 31, 2025 | -3.21 |
| Dec 31, 2024 | -3.46 |
| Sep 30, 2024 | -2.93 |
| Jun 30, 2024 | -3.07 |
| Mar 31, 2024 | -5.46 |
| Dec 31, 2023 | -31.64 |